Maricel Apuli sold $160K of BBIO stock

Maricel Apuli, Chief Accounting Officer of BridgeBio Pharma, Inc. (BBIO), sold 2,000 shares of BBIO stock worth $160K, per an SEC Form 4 filed Aug 3, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jul 30, 2026, 4 days before it was made public.

BBIO has moved -5.1% since the trade date, from $82.14 to $77.93 (Nov 9, 2026 close).